Prime Medicine Common Etf Analysis

PRME Etf  USD 7.11  0.79  10.00%   
Prime Medicine Common is undervalued with Real Value of 8.82 and Target Price of 22.17. The main objective of Prime Medicine etf analysis is to determine its intrinsic value, which is an estimate of what Prime Medicine Common is worth, separate from its market price. There are two main types of Prime Etf analysis: fundamental analysis and technical analysis.
The Prime Medicine etf is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Prime Medicine's ongoing operational relationships across important fundamental and technical indicators.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prime Medicine Common. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in population.

Prime Etf Analysis Notes

The fund maintains 99.55% of assets in stocks. Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange. To find out more about Prime Medicine Common contact Keith MD at 617 564 0013 or learn more at

Prime Medicine Common Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more etfs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Prime Medicine's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Prime Medicine Common or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Prime Medicine had very high historical volatility over the last 90 days
Net Loss for the year was (198.13 M) with loss before overhead, payroll, taxes, and interest of (86.72 M).
Prime Medicine Common currently holds about 146.66 M in cash with (165.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.39.
Roughly 66.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Foster-cheek Kaye I of 45000 shares of Prime Medicine at 7.68 subject to Rule 16b-3
The fund maintains 99.55% of its assets in stocks

Prime Medicine Common Upcoming and Recent Events

14th of March 2024
Upcoming Quarterly Report
9th of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
14th of March 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Prime Stock Institutional Investors

Mwg Management Ltd.2024-03-31
1.8 M
Baker Bros Advisors Lp2024-03-31
Geode Capital Management, Llc2024-03-31
916.9 K
Deerfield Management Co2024-03-31
885.3 K
State Street Corporation2024-03-31
778.8 K
Farallon Capital Management, L.l.c.2024-03-31
750 K
Ecor1 Capital, Llc2024-03-31
700 K
Greenwich Wealth Management Llc2024-03-31
578 K
Samsara Biocapital, Llc2024-03-31
540.3 K
Alphabet Inc2024-03-31
15.1 M
Ark Investment Management Llc2024-03-31
Note, although Prime Medicine's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Prime Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 853.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prime Medicine's market, we take the total number of its shares issued and multiply it by Prime Medicine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Prime Medicine Common has return on total asset (ROA) of (0.3971) % which means that it has lost $0.3971 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7827) %, meaning that it created substantial loss on money invested by shareholders. Prime Medicine's management efficiency ratios could be used to measure how well Prime Medicine manages its routine affairs as well as how well it operates its assets and liabilities.
The analysis of Prime Medicine's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Prime Medicine's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Prime Etf analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
Return On Assets
Return On Equity

Top Prime Medicine Common Etf Constituents

KRCKilroy Realty CorpStockDiversified REITs
AKRAcadia Realty TrustStockRetail REITs
HPPHudson Pacific PropertiesStockOffice Supplies
AVBAvalonBay CommunitiesStockFinTech
BXPBoston PropertiesStockFinTech
EQREquity ResidentialStockFinTech
SPGSimon Property GroupStockStores
FRTFederal Realty InvestmentStockRetail REITs
REXRRexford Industrial RealtyStockTrading
AREAlexandria Real EstateStockSRI Sustainable Growth
VNOVornado Realty TrustStockFinTech
ESSEssex Property TrustStockFinTech
MTSFFMitsui Fudosan CoPink SheetMitsui

Technical Drivers

As of the 18th of June 2024, Prime Medicine holds the Coefficient Of Variation of (6,918), insignificant risk adjusted performance, and Variance of 37.25. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prime Medicine, as well as the relationship between them. Please check Prime Medicine Common standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Prime Medicine Common is priced some-what accurately, providing market reflects its current price of 7.11 per share.

Prime Medicine Common Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Prime Medicine middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Prime Medicine Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Prime Medicine Common Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prime Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prime Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Prime Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Prime Medicine Predictive Daily Indicators

Prime Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Prime Medicine etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Prime Medicine Forecast Models

Prime Medicine's time-series forecasting models are one of many Prime Medicine's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prime Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Prime Etf Analysis

Etf analysis is the technique used by a trader or investor to examine and evaluate how Prime Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Prime shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as Prime Medicine. By using and applying Prime Etf analysis, traders can create a robust methodology for identifying Prime entry and exit points for their positions.
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.

Current Prime Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Prime analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Prime analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
22.17Strong Buy12Odds
Prime Medicine Common current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Prime analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Prime stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Prime Medicine Common, talking to its executives and customers, or listening to Prime conference calls.
Prime Analyst Advice Details

Prime Etf Analysis Indicators

Prime Medicine Common etf analysis indicators help investors evaluate how Prime Medicine etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Prime Medicine shares will generate the highest return on investment. By understating and applying Prime Medicine etf analysis, traders can identify Prime Medicine position entry and exit signals to maximize returns.
Begin Period Cash Flow201.1 M
Common Stock Shares Outstanding91 M
Total Stockholder Equity133.1 M
Tax Provision-465 K
Property Plant And Equipment Net36.6 M
Cash And Short Term Investments121.7 M
Cash41.6 M
Accounts Payable19.5 M
Net Debt-27.9 M
50 Day M A6.096
Total Current Liabilities56.4 M
Other Operating Expenses191.3 M
Non Current Assets Total50.9 M
Non Currrent Assets Other19.7 M
Stock Based Compensation13.9 M

Other Information on Investing in Prime Etf

Prime Medicine financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine security.